CLINICAL RESEARCH ON TRADITIONAL SIDDHA MEDICINE IN KALLADAIPPU (KIDNEY STONE)PATIENTS.

Phase 3

• Conditions: Health Condition 1: null- KALLADAIPPU(KIDNEY STONE)

• Registration Number: CTRI/2013/12/004203
• Lead Sponsor: AYOTHIDOSS PANDITHAR HOSPITA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 110

Inclusion Criteria

•Age between 20 and 60 years

•Both male and female patients

•Classical pain is described as pain from loin to groin, accompanied by nausea, vomiting and gaseous distension.

•Pain and or burning while passing urine.

•Patient with renal calculus detected on X-ray KUB or USG abdomen

•History of Recurrence of renal stone

•Stone size 5mm & > 5mm to < 10mm

•Urine routine which will show Crystals in urine.

•Patients are willing and able to give informed consent for participation in the study.

•Ability to understand study procedures and to comply with them for the entire length of the study.

Exclusion Criteria

•Stone size > 10 mm

•Obstruction requiring immediate surgery (Marked hydronephrosis)

•Pregnancy and Lactation

•women with childbearing potential without adequate contraception

•Use of disallowed concomitant medications (NSAID)

•Patient taking any other lithotriptic agent

•History of Diabetes/ Hypertension

•History of hepatic/ renal/ cardiac disease

•History of taking treatment for any other ailments.

•History of drug/alcohol abuse

oExperiencing habitual alcohol-related legal problems.

oRepeated drinking despite ongoing alcohol-related relationship problems.

oFailure to attend to important responsibilities at work, school or college, or home.

•Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

•Treatment with another investigational drug or other intervention (within a period of 30 days)

•Participated in any research study within the past six months.

•Donated blood within the past six months.

•Any psychiatric condition that could prevent patient from signing the informed consent or could put the patient at an unacceptable risk in case of participating in the trial

•Medical condition, laboratory finding, or physical exam finding (e.g., vital signs outside of specific range) that precludes participation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified